1. Role of Presenilin-1 in Aggressive Human Melanoma
   Julia Sidor et al, 2022, International Journal of Molecular Sciences CrossRef
2. Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
   Cristina Fortuno et al, 2024, JCO Precision Oncology CrossRef
3. Genetic testing for familial melanoma
   Clare A. PRIMIERO et al, 2024, Italian Journal of Dermatology and Venereology CrossRef
4. Transcriptomic analysis of genes associated with vitamin D receptor signalling reveals differences between skin cancers
   Juliana Polizel Ocanha‐Xavier et al, 2024, Experimental Dermatology CrossRef
5. Germline mutations predisposing to melanoma and associated malignancies and syndromes: a narrative review
   Irene López Riquelme et al, 2024, International Journal of Dermatology CrossRef
6. Current insights and future directions of Li-Fraumeni syndrome
   Mohammad-Salar Hosseini, 2024, Discover Oncology CrossRef
7. Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis
   Rensen Ran et al, 2022, Molecular Oncology CrossRef
8. Management of cutaneous melanoma: radiologists challenging and risk assessment
   Vincenza Granata et al, 2022, La radiologia medica CrossRef
9. Choroidal metastasis in a patient with myxoid liposarcoma of the gluteal region – A case report
   Bhavsar Kaushal et al, 2024, Indian Journal of Ophthalmology - Case Reports CrossRef
10. Genetic Testing for Successive Cancer Treatment
    Desh Nidhi Singh et al, 2023, Cureus CrossRef
11. TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma
    Marlene Richter Jensen et al, 2023, Human Genetics and Genomics Advances CrossRef
12. Unveiling the genetic landscape of hereditary melanoma: From susceptibility to surveillance
    Chenming Zheng et al, 2024, Cancer Treatment and Research Communications CrossRef